According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...

If you have metastatic non-small-cell lung cancer, or NSCLC, breathing exercises are often the first step toward recovery.

NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

Today marks two years since WTOP’s Neal Augenstein was diagnosed with stage 4 lung cancer. He reflects on where he’s been in ...

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

A $2 million donation creates The Barbara C. Killian Thoracic Oncology Fund to support patients who battle cancer like Mrs.

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...